alzheimer-s-disease

Documents about alzheimer-s-disease

• Graph-Based Biomarker Discovery and Interpretation for Alzheimer's Disease#183173arXiv (OAI)
• How does type 2 diabetes modify the risk of Alzheimer's disease?#209321NCBI PubMed Central
• Hippocampal subregional texture features associated with Alzheimer’s disease severity and cognition.#209470NCBI PubMed Central
• Robust transcriptomic signatures of Alzheimer's disease progression: validated explainable AI approach.#213872NCBI PubMed Central
• Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer's disease pathology.#218811NCBI PubMed Central
• Region-Specific Brain Atrophy Across Alzheimer’s Disease Stages in the NACC Dataset#225155OSF
• The relationship between personality traits and Alzheimer’s disease: a narrative review.#263149NCBI PubMed Central
• Mechanisms of increased Alzheimer's Disease pathology with R47H and R62H TREM2 variants#264596bioRxiv / medRxiv
• Tanycytic degeneration impairs tau clearance and contributes to Alzheimer’s disease pathology#268584HAL (France)
• Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease.#269427NCBI PubMed Central
• Atrophy signature for alpha-synuclein copathology in Alzheimer's disease.#269580NCBI PubMed Central
• Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology.#275382NCBI PubMed Central
• Nanoparticles that target nonamyloid and nontau pathways in Alzheimer's disease.#297208NCBI PubMed Central
• Uncertainty-Aware Longitudinal Forecasting of Alzheimer's Disease Progression Using Deep Learning#303275arXiv CS
• The mechanisms and strategies for Alzheimer’s disease prevention: An update.#317579NCBI PubMed Central
• Multitarget Actions of Pentacyclic Triterpenic Acids in Alzheimer's Disease: Mechanistic Insights.#317590NCBI PubMed Central
• APOE ε4 and Alzheimer's disease biomarkers in an American Indian community.#367966NCBI PubMed Central
• Aging in a highly polluted world: challenges and solutions to prevent Alzheimer's disease.#382386NCBI PubMed Central
• Modeling Alzheimer's disease with brain organoids: mechanisms, applications, and future directions.#396232NCBI PubMed Central
• Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States#398143bioRxiv / medRxiv
• AI-Enabled Modeling for Alzheimer's Disease Risk Prediction and Validation.#418566NCBI PubMed Central
• New Genetic Associations Between Alzheimer's Disease and Its Key Risk Factors.#420882NCBI PubMed Central
• A Neurosymbolic Approach for Explainable Early Diagnosis of Alzheimer's Disease#422245arXiv CS
• Plasma proteomic profiles of Alzheimer's disease and neurodegeneration in African cohorts.#449752NCBI PubMed Central
• An interpretable multimodal ensemble assessment framework for Alzheimer's disease cognitive staging.#472519NCBI PubMed Central
• Amyloid-PET pipeline choice influences classification of preclinical Alzheimer’s disease#478521Europe PMC
• Blood-based biomarkers and 20-year risk of clinically diagnosed Alzheimer's disease#480194bioRxiv / medRxiv
• Data Management and Sharing Plan for: ApoE and heparan sulfate interactions in Alzheimer's disease.#649101UNC Dataverse Dataverse OAI Archive
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11947DataCite
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11948DataCite
• Multicenter study on the effect of CPAP on cognitive function in patients with mild cognitive impairment and Alzheimer’s disease with OSA (DemCPAP): presentation of the protocol and preliminary data#482805IRIS
• Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution#251777Repositorio UNAB
• Table 1_Ershiwuwei Shanhu Pill ameliorates cognitive impairment in Alzheimer’s disease mice by remodeling gut microbiota and host serum metabolites.xls#291333Figshare
• The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis#276425Repositorio de datos de investigación de la Universidad de Chile Dataverse OAI Archive
• Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia.#480974NCBI PubMed Central
• Indole Metabolites as Modulators of Human Cholinesterases: A Kinetic and Molecular Docking Study with Comparison to Alzheimer's Drugs#315267Muğla Sıtkı Koçman University Institutional Repository
• Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: an analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)#319784bioRxiv / medRxiv
• Leveraging electronic health records to examine differential clinical outcomes in people with Alzheimer's disease.#146177NCBI PubMed Central
• Reduced inhibition, bursting, and accelerated oscillations drive early hippocampal hyperactivity in Alzheimer's disease in vivo.#220914NCBI PubMed Central
• Deep Learning and Machine Learning for Early Detection of Alzheimer's Disease: A Systematic Review and Meta-Analysis#296520bioRxiv / medRxiv
• An information-theoretic evaluation framework for CNN-LSTM-based Alzheimer's disease classification from structural MRI.#479300NCBI PubMed Central
• Comparator supplement patterns qualify the clinical interpretation of an EHR-derived glucosamine signal in Alzheimer's disease#481630bioRxiv / medRxiv
• ARRIVE 2.0 Checklist: Neuroprotective Effects of Treadmill Training on Irisin/EGR-1/PSD-95 in Alzheimer's Disease Model Item#300596Figshare
• An Examination of Lifetime Traumatic Brain Injury and Anti-Inflammatory Medication Use in the Risk for Alzheimer's Disease#433115DigitalCommons@USU
• Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease.#404260NCBI PubMed Central
• Probing the Roles of Connexin 43 Hemichannels in a Mouse Model of Alzheimer's Disease#176225DigitalCommons@USU
• Entre el silenci dels records: recerca d’una memòria perduda. Nous enfocaments terapèutics en la malaltia de l’Alzheimer#185002Dipòsit Digital de la Universitat de Barcelona
• Neuronutrition for the Primary Prevention of Alzheimer’s Disease for Women in Perimenopause and Early Menopause#173146Harvard DASH
• Intracellular protein GBF1 displays significant associations with amyloid pathology in Alzheimer's disease.#25679NCBI PubMed Central
• Dysfunction of the episodic memory network in the Alzheimer's disease cascade#123268Europe PMC